| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
|
60,372 |
55,289 |
$14.76M |
| 99284 |
|
38,825 |
33,636 |
$9.63M |
| 96374 |
|
22,896 |
19,768 |
$1.24M |
| 99282 |
|
7,196 |
6,870 |
$1.16M |
| 87426 |
|
8,497 |
8,038 |
$176K |
| 43239 |
|
242 |
194 |
$92K |
| 96372 |
|
4,839 |
4,222 |
$81K |
| 97110 |
|
2,553 |
589 |
$67K |
| 99285 |
|
190 |
156 |
$50K |
| 97802 |
|
581 |
545 |
$46K |
| 11042 |
|
784 |
338 |
$42K |
| 87635 |
|
1,212 |
1,139 |
$34K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
632 |
583 |
$33K |
| 93306 |
|
167 |
132 |
$26K |
| 45380 |
|
36 |
28 |
$10K |
| 96375 |
|
3,190 |
2,727 |
$10K |
| 45385 |
|
16 |
12 |
$8K |
| 97140 |
|
1,255 |
351 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
320 |
302 |
$8K |
| 80053 |
|
31,944 |
27,424 |
$7K |
| 74177 |
|
579 |
507 |
$7K |
| 87502 |
|
12,499 |
11,793 |
$7K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
521 |
142 |
$6K |
| G0378 |
Hospital observation service, per hour |
22 |
14 |
$5K |
| 99281 |
|
41 |
38 |
$4K |
| 71045 |
|
8,547 |
7,429 |
$4K |
| 85027 |
|
40,574 |
34,832 |
$3K |
| 93005 |
|
14,967 |
12,536 |
$3K |
| 70450 |
|
1,141 |
984 |
$3K |
| 87651 |
|
3,116 |
2,998 |
$2K |
| 71046 |
|
4,320 |
3,884 |
$2K |
| 97162 |
|
15 |
13 |
$1K |
| 81025 |
|
13,459 |
12,362 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
90 |
40 |
$927.42 |
| 83690 |
|
8,710 |
7,629 |
$688.01 |
| 81001 |
|
17,010 |
15,035 |
$593.58 |
| 87430 |
|
1,748 |
1,673 |
$518.26 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
12,233 |
11,126 |
$463.53 |
| 87081 |
|
540 |
511 |
$423.90 |
| 96361 |
|
581 |
499 |
$371.25 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,776 |
3,461 |
$298.73 |
| 80048 |
|
4,874 |
4,240 |
$291.61 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,106 |
1,027 |
$236.21 |
| 84484 |
|
7,452 |
5,683 |
$219.94 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,651 |
7,107 |
$166.22 |
| 87631 |
|
153 |
149 |
$141.07 |
| 80307 |
|
928 |
814 |
$120.52 |
| 74022 |
|
13 |
12 |
$97.18 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
335 |
281 |
$55.48 |
| 87503 |
|
1,390 |
1,323 |
$49.99 |
| 81003 |
|
5,800 |
5,189 |
$44.55 |
| 83735 |
|
2,717 |
2,278 |
$42.44 |
| 83880 |
|
138 |
114 |
$37.07 |
| 85610 |
|
1,521 |
1,261 |
$24.10 |
| 88305 |
|
23 |
14 |
$22.56 |
| 87807 |
|
52 |
52 |
$11.43 |
| 87070 |
|
1,293 |
1,263 |
$8.21 |
| 80076 |
|
723 |
640 |
$8.17 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
560 |
541 |
$6.54 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
15 |
15 |
$0.24 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
44 |
43 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
158 |
152 |
$0.00 |
| 85378 |
|
147 |
129 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
51 |
44 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
178 |
157 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
29 |
25 |
$0.00 |
| 84702 |
|
12 |
12 |
$0.00 |
| 82248 |
|
62 |
52 |
$0.00 |
| 74176 |
|
13 |
13 |
$0.00 |
| 87186 |
|
16 |
13 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
18 |
15 |
$0.00 |
| 80143 |
|
12 |
12 |
$0.00 |
| 87420 |
|
12 |
12 |
$0.00 |
| 87634 |
|
15 |
13 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
15 |
13 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12 |
12 |
$0.00 |
| 80179 |
|
12 |
12 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
105 |
98 |
$0.00 |
| 87086 |
|
174 |
150 |
$0.00 |
| 82550 |
|
220 |
174 |
$0.00 |
| 84703 |
|
358 |
328 |
$0.00 |
| 85730 |
|
345 |
288 |
$0.00 |
| 82150 |
|
77 |
65 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
121 |
116 |
$0.00 |
| A9270 |
Non-covered item or service |
38 |
14 |
$0.00 |
| 36000 |
|
63 |
57 |
$0.00 |
| 83605 |
|
17 |
13 |
$0.00 |
| 88304 |
|
12 |
12 |
$0.00 |
| 82077 |
|
40 |
38 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
67 |
67 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
34 |
27 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
14 |
12 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
16 |
12 |
$0.00 |